Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02308280
Title Nonmyeloablative Allogeneic Stem Cell Transplant Followed by Bortezomib in High-risk Multiple Myeloma Patients
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Maisonneuve-Rosemont Hospital
Age Groups: adult
Covered Countries CAN

Facility Status City State Zip Country Details
Hôpital Maisonneuve-Rosemont Montreal Quebec H1T 2M4 Canada Details
*Shaded cells indicate that there was no data available from for the field